{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:14:43Z","timestamp":1792700083731,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017668","name":"Anhui Provincial Key Research and Development Plan","doi-asserted-by":"publisher","award":["2022e07020022"],"award-info":[{"award-number":["2022e07020022"]}],"id":[{"id":"10.13039\/501100017668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170221"],"award-info":[{"award-number":["82170221"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.phymed.2025.156483","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T19:46:41Z","timestamp":1738871201000},"page":"156483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Tetrandrine alleviates macrophage activation syndrome after CAR-T cell therapy"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5797-467X","authenticated-orcid":false,"given":"Youming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5594-0303","authenticated-orcid":false,"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0813-3847","authenticated-orcid":false,"given":"Yuanli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.phymed.2025.156483_bib0001","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1158\/2643-3230.BCD-21-0181","article-title":"Blockade or deletion of IFN\u03b3 reduces macrophage activation without compromising CAR T-cell function in hematologic malignancies","volume":"3","author":"Bailey","year":"2022","journal-title":"Blood Cancer Discov."},{"issue":"1","key":"10.1016\/j.phymed.2025.156483_bib0002","first-page":"205","article-title":"Strategies for the treatment of pneumoconiosis","volume":"8","author":"Banks","year":"1993","journal-title":"Occup. Med."},{"key":"10.1016\/j.phymed.2025.156483_bib0003","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.phytochem.2016.02.005","article-title":"Tetrandrine\u2013A molecule of wide bioactivity","volume":"125","author":"Bhagya","year":"2016","journal-title":"Phytochemistry"},{"issue":"26","key":"10.1016\/j.phymed.2025.156483_bib0004","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of chimeric antigen receptor T cells: recognition and management","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2025.156483_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101719","article-title":"Late haemophagocytic lymphohistiocytosis in a patient treated with Axicabtagene ciloleucel","volume":"75","author":"Cutini","year":"2022","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.phymed.2025.156483_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107112","article-title":"Targeting autophagy to counteract neuroinflammation: a novel antidepressant strategy","volume":"202","author":"Gan","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"9","key":"10.1016\/j.phymed.2025.156483_bib0007","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/jor.23155","article-title":"Tetrandrine suppresses articular inflammatory response by inhibiting pro-inflammatory factors via NF-\u03bab inactivation","volume":"34","author":"Gao","year":"2016","journal-title":"J. Orthop. Res."},{"issue":"4","key":"10.1016\/j.phymed.2025.156483_bib0008","doi-asserted-by":"crossref","first-page":"e13845","DOI":"10.1111\/1440-1681.13845","article-title":"Scutellarin inhibits oleic acid induced vascular smooth muscle foam cell formation via activating autophagy and inhibiting NLRP3 inflammasome activation","volume":"51","author":"Gao","year":"2024","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"25","key":"10.1016\/j.phymed.2025.156483_bib0009","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2017-02-769208","article-title":"Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults","volume":"129","author":"Gardner","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.phymed.2025.156483_bib0010","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41591-018-0041-7","article-title":"CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade","volume":"24","author":"Giavridis","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2025.156483_bib0011","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainres.2011.01.103","article-title":"Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-\u03bab activation in a rat model of Alzheimer's disease induced by amyloid-\u03b2(1-42)","volume":"1384","author":"He","year":"2011","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.phymed.2025.156483_bib0012","doi-asserted-by":"crossref","first-page":"e00653","DOI":"10.1002\/prp2.653","article-title":"Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID-19","volume":"8","author":"Heister","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"issue":"15","key":"10.1016\/j.phymed.2025.156483_bib0013","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2025.156483_bib0014","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40164-020-00166-2","article-title":"Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytes","volume":"9","author":"Kang","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.phymed.2025.156483_bib0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and Cytokine shock syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell."},{"issue":"19","key":"10.1016\/j.phymed.2025.156483_bib0016","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108863","article-title":"Autophagy in major human diseases","volume":"40","author":"Klionsky","year":"2021","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.phymed.2025.156483_bib0017","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1634\/theoncologist.2018-0028","article-title":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome","volume":"23","author":"Le","year":"2018","journal-title":"Oncologist."},{"issue":"11","key":"10.1016\/j.phymed.2025.156483_bib0018","first-page":"6107","article-title":"Tetrandrine induces apoptosis in Human nasopharyngeal carcinoma NPC-TW 039 cells by endoplasmic reticulum stress and Ca(2+)\/calpain pathways","volume":"37","author":"Liu","year":"2017","journal-title":"Anticancer Res."},{"issue":"26","key":"10.1016\/j.phymed.2025.156483_bib0019","doi-asserted-by":"crossref","first-page":"40800","DOI":"10.18632\/oncotarget.8315","article-title":"Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.phymed.2025.156483_bib0020","article-title":"Tetrandrine modulates rheb-mTOR signaling-mediated selective autophagy and protects pulmonary fibrosis","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2025.156483_bib0021","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8589121","article-title":"Tetrandrine ameliorates rheumatoid arthritis in mice by alleviating neutrophil activities","volume":"2022","author":"Lu","year":"2022","journal-title":"Evid. Based. Complement. Alternat. Med."},{"issue":"11","key":"10.1016\/j.phymed.2025.156483_bib0022","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jphp.13339","article-title":"Tetrandrine: a review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems","volume":"72","author":"Luan","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"10.1016\/j.phymed.2025.156483_bib0023","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2025.156483_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.978600","article-title":"Progress on structural modification of Tetrandrine with wide range of pharmacological activities","volume":"13","author":"Mo","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.phymed.2025.156483_bib0025","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/ped.13064","article-title":"Hemophagocytic lymphohistiocytosis: pathogenesis, diagnosis, and management","volume":"58","author":"Morimoto","year":"2016","journal-title":"Pediatr. Int."},{"issue":"26","key":"10.1016\/j.phymed.2025.156483_bib0026","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.phymed.2025.156483_bib0027","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/vhrm.1.2.119.64083","article-title":"Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium","volume":"1","author":"Norata","year":"2005","journal-title":"Vasc. Health Risk. Manage"},{"issue":"6","key":"10.1016\/j.phymed.2025.156483_bib0028","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2025.156483_bib0029","first-page":"1","article-title":"Adult secondary hemophagocytic lymphohistiocytosis","author":"Obayo","year":"2020","journal-title":"EJHaem."},{"issue":"2","key":"10.1016\/j.phymed.2025.156483_bib0030","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jha2.113","article-title":"Adult secondary hemophagocytic lymphohistiocytosis","volume":"1","author":"Obayo","year":"2020","journal-title":"EJHaem."},{"issue":"4","key":"10.1016\/j.phymed.2025.156483_bib0031","doi-asserted-by":"crossref","first-page":"507","DOI":"10.5858\/arpa.2020-0802-RA","article-title":"Hemophagocytic lymphohistiocytosis","volume":"146","author":"Ponnatt","year":"2022","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"3","key":"10.1016\/j.phymed.2025.156483_bib0032","doi-asserted-by":"crossref","first-page":"e1123","DOI":"10.1038\/cddis.2014.84","article-title":"Tetrandrine blocks autophagic flux and induces apoptosis via energetic impairment in cancer cells","volume":"5","author":"Qiu","year":"2014","journal-title":"Cell Death. Dis."},{"issue":"9927","key":"10.1016\/j.phymed.2025.156483_bib0033","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"issue":"6225","key":"10.1016\/j.phymed.2025.156483_bib0034","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1126\/science.1258758","article-title":"Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment","volume":"347","author":"Sakurai","year":"2015","journal-title":"Science"},{"issue":"26","key":"10.1016\/j.phymed.2025.156483_bib0035","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric antigen receptor T cells in refractory B-cell lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.phymed.2025.156483_bib0036","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00296-020-04636-y","article-title":"Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic","volume":"41","author":"Soy","year":"2021","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.phymed.2025.156483_bib0037","first-page":"3383","article-title":"Clinical efficacy of acetylcysteine combined with tetrandrine tablets in the treatment of silicosis and the effect on serum IL-6 and TNF-\u03b1","volume":"18","author":"Sun","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"9","key":"10.1016\/j.phymed.2025.156483_bib0038","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41419-018-0918-x","article-title":"The biological basis and clinical symptoms of CAR-T therapy-associated toxicites","volume":"9","author":"Titov","year":"2018","journal-title":"Cell Death. Dis."},{"issue":"6","key":"10.1016\/j.phymed.2025.156483_bib0039","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1073\/pnas.1820704116","article-title":"Specific sequences of infectious challenge lead to secondary hemophagocytic lymphohistiocytosis-like disease in mice","volume":"116","author":"Wang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"issue":"14","key":"10.1016\/j.phymed.2025.156483_bib0040","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa1914347","article-title":"KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma","volume":"382","author":"Wang","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.phymed.2025.156483_bib0041","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.7150\/ijbs.59534","article-title":"The role of CD4(+)FoxP3(+) regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment","volume":"17","author":"Wang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"8","key":"10.1016\/j.phymed.2025.156483_bib0042","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.tiv.2011.09.024","article-title":"Tetrandrine down-regulates ERK\/NF-\u03bab signaling and inhibits activation of mesangial cells","volume":"25","author":"Wu","year":"2011","journal-title":"Toxicol. In. Vitro"},{"issue":"6","key":"10.1016\/j.phymed.2025.156483_bib0043","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.3892\/mmr.2016.5187","article-title":"Tetrandrine suppresses \u03b2\u2011glucan\u2011induced macrophage activation via inhibiting NF\u2011\u03bab, ERK and STAT3 signaling pathways","volume":"13","author":"Xu","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.phymed.2025.156483_bib0044","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.leukres.2005.08.005","article-title":"Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia","volume":"30","author":"Xu","year":"2006","journal-title":"Leuk. Res."},{"issue":"9","key":"10.1016\/j.phymed.2025.156483_bib0045","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1111\/jcmm.13141","article-title":"Tetrandrine, an agonist of aryl hydrocarbon receptor, reciprocally modulates the activities of STAT3 and STAT5 to suppress Th17 cell differentiation","volume":"21","author":"Yuan","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.phymed.2025.156483_bib0046","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bcp.2015.11.025","article-title":"Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and treg cells via the aryl hydrocarbon receptor","volume":"101","author":"Yuan","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.phymed.2025.156483_bib0047","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122773","article-title":"Lym-1 chimeric antigen receptor T cells exhibit potent anti-tumor effects against B-cell lymphoma","volume":"18","author":"Zheng","year":"2017","journal-title":"Int. J. Mol. Sci."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325001242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325001242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:12:14Z","timestamp":1774962734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325001242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":47,"alternative-id":["S0944711325001242"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156483","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetrandrine alleviates macrophage activation syndrome after CAR-T cell therapy","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156483"}}